Acorda Signs Settlement With Mylan on Generic Ampyra

Date : 08/03/2018 @ 1:39PM
Source : Dow Jones News
Stock : Acorda Therapeutics, Inc. (ACOR)
Quote : 15.89  0.0 (0.00%) @ 12:00PM

Acorda Signs Settlement With Mylan on Generic Ampyra

Acorda Therapeutics, Inc. (NASDAQ:ACOR)
Historical Stock Chart

6 Months : From Jun 2018 to Dec 2018

Click Here for more Acorda Therapeutics, Inc. Charts.
   By Michael Dabaie 

Biotechnology company Acorda Therapeutics Inc. (ACOR) on Friday said it signed a conditioned settlement agreement with Mylan N.V. (MYL) and affiliates over Acorda's multiple-sclerosis drug Ampyra.

Under the settlement agreement, Mylan will be permitted to market its generic version of Ampyra in the U.S. sometime in 2025 or earlier under certain circumstances, Acorda said in a filing with the Securities and Exchange Commission.

Acorda also said it signed interim agreements with Teva Pharmaceutical Industries Ltd. (TEVA) and Hikma Pharmaceuticals PLC (HKMPY) concerning their patent litigation relating to Ampyra.

Acorda is awaiting a decision of the U.S. Court of Appeals for the Federal Circuit in its appeal of a 2017 U.S. district court decision that invalidated four of its Ampyra patents set to expire between 2025 and 2027.

Acorda earlier this week reiterated it sees Ampyra 2018 net revenue of $330 million to $350 million.


Write to Michael Dabaie at


(END) Dow Jones Newswires

August 03, 2018 09:24 ET (13:24 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.

Latest ACOR Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.